LINC00319 stimulates CD133+CD144+ TU177 cell self-renewal ability and tumorigenicity by upregulating HMGB3 via recruitment of E2F1 in laryngeal squamous cell carcinoma [35]. Here, E2F1 is linked to laryngeal squamous cell carcinoma.